Article
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation.
Antimicrobial agents and chemotherapy - 1 Feb 2010
Mukaide Motokazu, Tanaka Yasuhito, Shin-I Tadasu, Yuen Man-Fung, Kurbanov Fuat, Yokosuka Osamu, Sata Michio, Karino Yoshiyasu, Yamada Gotaro, Sakaguchi Kohsaku, Orito Etsuro, Inoue Manami, Baqai Sumbella, Lai Ching-Lung, Mizokami Masashi
Abstract excerpt
The mechanism by which entecavir resistance (ETVr) substitutions of hepatitis B virus (HBV) can induce breakthrough (BT) during ETV therapy is largely unknown. We conducted a cross-sectional study of 49 lamivudine (LVD)-refractory patients and 59 naïve patients with chronic hepatitis B. BT was ob...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
